bioRxiv/medRxiv TRiP Review Activity

6,534 Reviews — eLife — All Subjects

Most recent first Previous |  Page 299: Articles 2981-2990  | Next

Spontaneous body wall contractions stabilize the fluid microenvironment that shapes host-microbe associations
Nawroth, J. C., Giez, C., Klimovich, A., Kanso, E. A., Bosch, T. C.
10.1101/2022.11.30.518486 — Posted: 2022-12-02 — Discussion: 2023-06-17  eLife
p38γ and p38δ modulate innate immune response by regulating MEF2D activation
Cuenda, A., Escos, A., Diaz-Mora, E., Fajardo, P., Gonzalez-Romero, D., Risco, A., Martin-Gomez, J., Bonneil, E., Sonenberg, N., Jafarnejad, S. M., Pattison, M., Sanz-Ezquerro, J. J., Ley, S. C.
10.1101/2022.12.09.519777 — Posted: 2022-12-09 — Discussion: 2023-06-17  eLife
Spatial determination and prognostic impact of the fibroblast transcriptome in pancreatic ductal adenocarcinoma
Croft, W., Pearce, H., Margielewska-Davies, S., Lim, L., Nicol, S. M., Zayou, F., Blakeway, D., Marcon, F., Powell-Brett, S., Mahon, B., Merard, R., Zuo, J., Middleton, G., Roberts, K., Brown, R. M., Moss, P.
10.1101/2023.01.20.524883 — Posted: 2023-01-21 — Discussion: 2023-06-17  eLife
The role of B cells in immune cell activation in polycystic ovary syndrome
Ascani, A., Torstensson, S., Risal, S., Lu, H., Eriksson, G., Li, C., Teshl, S., Menezes, J., Sandor, K., Ohlsson, C., Svensson, C., Karlsson, M., Stradner, M. H., Obermayer-Pietsch, B., Stener-Victorin, E.
10.1101/2023.01.26.525671 — Posted: 2023-01-27 — Discussion: 2023-06-17  eLife
Genome-wide screen reveals Rab12 GTPase as a critical activator of pathogenic LRRK2 kinase
Dhekne, H. S., Tonelli, F., Yeshaw, W. M., Chiang, C. Y., Limouse, C., Jaimon, E., Purlyte, E., Alessi, D. R., Pfeffer, S. R.
10.1101/2023.02.17.529028 — Posted: 2023-02-18 — Discussion: 2023-06-17  eLife
Metformin regulates bone marrow stromal cells to accelerate bone healing in diabetic mice
Guo, Y., Wei, J., Liu, C., Li, X., Yan, W.
10.1101/2023.04.05.535802 — Posted: 2023-04-06 — Discussion: 2023-06-17  eLife
Development and Biophysical Characterization of a Humanized FSH-Blocking Monoclonal Antibody Therapeutic Formulated at an Ultra-High Concentration
Rojekar, S., Pallapati, A. R., Gimenez-Roig, J., Korkmaz, F., Sultana, F., Sant, D., Haeck, C. M., Macdonald, A., Kim, S.-M., Rosen, C. J., Barak, O., Meseck, M., Caminis, J., Lizneva, D., Yuen, T., Zaidi, M.
10.1101/2023.05.11.540323 — Posted: 2023-05-11 — Discussion: 2023-06-17  eLife
SARS-CoV-2 Uses CD4 to Infect T Helper Lymphocytes
Davanzo, G. G., Codo, A. C., Brunetti, N. S., Boldrini, V. O., Knittel, T. L., Monterio, L. B., de Moraes, D., Ferrari, A. J. R., de Souza, G. F., Muraro, S. P., Profeta, G. . S., Wassano, N. S., Santos, L. N., Carregari, V. . C., Dias, A. . H. S., Virgilio-da-Silva, J. V., Castro, I., Silva-Costa, L. . C., Palma, A., Mansour, E., Ulaf, R. G., Bernardes, A. F., Nunes, T. A., Ribeiro, L. C., Agrela, M. V., Moretti, M. L., Buscaratti, L. I., Crunfli, F., Ludwig, R. . G., Gerhardt, J. A., Seste-Costa, R., Forato, J., Amorin, M. . R., Texeira, D. A. T., Parise, P. L., Martini, M. C., Bispo-dos-San
10.1101/2020.09.25.20200329 — Posted: 2020-09-28 — Discussion: 2023-06-17  eLife
FUS regulates RAN translation through modulating the G-quadruplex structure of GGGGCC repeat RNA in C9orf72-linked ALS/FTD
Fujino, Y., Ueyama, M., Ishiguro, T., Ozawa, D., Sugiki, T., Ito, H., Murata, A., Ishiguro, A., Gendron, T., Mori, K., Tokuda, E., Taminato, T., Konno, T., Koyama, A., Kawabe, Y., Takeuchi, T., Furukawa, Y., Fujiwara, T., Ikeda, M., Mizuno, T., Mochizuki, H., Mizusawa, H., Wada, K., Ishikawa, K., Onodera, O., Nakatani, K., Taguchi, H., Petrucelli, L., Nagai, Y.
10.1101/2022.11.01.514717 — Posted: 2022-11-01 — Discussion: 2023-06-16  eLife
Precision RNAi using synthetic shRNAmir target sites
Hoffmann, T., Hörmann, A., Corcokovic, M., Zmajkovic, J., Hinterndorfer, M., Salkanovic, J., Spreitzer, F., Köferle, A., Gitschtaler, K., Popa, A., Oberndorfer, S., Andersch, F., Schaefer, M., Fellner, M., Budano, N., Ruppert, J. G., Chetta, P., Wurm, M., Zuber, J., Neumüller, R. A.
10.1101/2022.11.24.517802 — Posted: 2022-11-25 — Discussion: 2023-06-16  eLife

Evaluation Sources